Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso SB Sirima, A Ouedraogo, N Barry, M Siribie, AB Tiono, I Nébié, AT Konaté, ... International Journal of Infectious Diseases 102, 517-523, 2021 | 30 | 2021 |
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial SB Sirima, A Ouedraogo, N Barry, M Siribie, A Tiono, I Nébié, A Konaté, ... International Journal of Infectious Diseases 108, 465-472, 2021 | 26 | 2021 |
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated … M Siribie, AM Tchouatieu, I Soulama, JMT Kaboré, Y Nombré, D Hien, ... BMJ open 11 (2), e040220, 2021 | 7 | 2021 |
Contribution of the Rapid LAMP-Based Diagnostic Test (RLDT) to the Evaluation of Enterotoxigenic Escherichia coli (ETEC) and Shigella in Childhood Diarrhea in … A Héma, SS Sermé, J Sawadogo, A Diarra, A Barry, AZ Ouédraogo, ... Microorganisms 11 (11), 2809, 2023 | 1 | 2023 |
PA-658 Shigella incidence and resistance to commonly used antibiotics in children under five years of age living in a community setting in Ouagadougou, Burkina Faso A Hema, A Diarra, BI Soulama, D Hien, JW Sawadogo, A Barry, S Sermé, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |